Request a call back

Send an Inquiry

Key visual for «Транексам» medicine

Key visual for «Транексам» medicine portfolio

Hemostatic drug. An inhibitor of fibrinolysis. Specifically inhibits the activation of plasminogen and its conversion into plasmin. It has local and systemic hemostatic effect of bleeding, associated with increased fibrinolysis (pathology of platelets, menorragii).

Indications

  • Bleeding or risk of bleeding against the backdrop of generalized enhance fibrinolysis;
  • Bleeding or risk of bleeding against the backdrop of strengthening local fibrinolysis.

Slogan:

«When result matters!»

TA:

For doctors